SCHEMBL14679917

SCHEMBL14679917

O=C(OC[C@H]1O[C@H](O[C@]2(COC(=O)c3ccccc3)O[C@H](COC(=O)c3ccccc3)[C@H](OC(=O)c3ccccc3)C2OC(=O)c2ccccc2)[C@@H](OC(=O)c2ccccc2)C1OC(=O)c1ccccc1)c1ccccc1

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ MAPT P10636 1/20 0.50
▸ PTPN1 P18031 4/20 0.49
▸ USP2 O75604 2/20 0.44
▸ POLB P06746 2/20 0.44
▸ MEN1 O00255 1/20 0.44
▸ KMT2A Q03164 1/20 0.44
▸ PTPN2 P17706 1/20 0.42
▸ PTPN11 Q06124 1/20 0.42
▸ ANTXR2 P58335 3/20 0.41
▸ ALDH1A1 P00352 1/20 0.41
▸ F11 P03951 2/20 0.41
▸ CA1 P00915 2/20 0.41
▸ CA2 P00918 2/20 0.41
▸ MAPK1 P28482 2/20 0.41
▸ TMPRSS2 O15393 1/20 0.41
▸ PDE5A O76074 1/20 0.41
▸ HMGCR P04035 1/20 0.41
▸ CYP1A2 P05177 1/20 0.41
▸ LCK P06239 1/20 0.41
▸ FYN P06241 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14680922 1.00 MAPT (0.50) MAPTPTPN1USP2POLBMEN1
SCHEMBL14903566 0.99 MAPT (0.49) MAPTPTPN1USP2POLBMEN1
SCHEMBL10310585 0.99 MAPT (0.49) MAPTPTPN1USP2POLBMEN1
SCHEMBL343136 0.99 MAPT (0.49) MAPTPTPN1USP2POLBMEN1
SCHEMBL14906687 0.99 MAPT (0.49) MAPTPTPN1USP2POLBMEN1
SCHEMBL10310560 0.99 MAPT (0.49) MAPTPTPN1USP2POLBMEN1
SCHEMBL22774113 0.95 MAPT (0.46) MAPTPTPN1USP2POLBMEN1
SCHEMBL20724710 0.93 MAPT (0.46) MAPTPTPN1USP2POLBMEN1
SCHEMBL21768322 0.89 EPHX2 (0.43) MAPTPTPN1USP2POLBMEN1
SCHEMBL11032157 0.89 MAPT (0.46) MAPTPTPN1ALDH1A1SLC22A1SYNJ2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8888907-B2 Solid phase change ink compositions comprising oxazolines XEROX CORPORATION (US) 2014-11-18 — — US disclosed
US-20130032057-A1 SOLID PHASE CHANGE INK COMPOSITIONS COMPRISING OXAZOLINES XEROX CORPORATION (US) 2013-02-07 — — US disclosed
Send feedback